Organometallic Anticancer Compounds

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Organometallic Anticancer Compounds

Gilles Gasser,* Ingo Ott,* and Nils Metzler-Nolte* Institute of Inorganic Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland, Institute of Pharmaceutical Chemistry, Technische Universit€ at Braunschweig, Beethovenstrasse 55, 38106 Braunschweig, Germany, and Chair of Inorganic Chemistry I, Bioinorganic Chemistry, Faculty of Chemistry and Biochemistry, Ruhr Univ...

متن کامل

Catalytic organometallic anticancer complexes.

Organometallic complexes offer chemistry that is not accessible to purely organic molecules and, hence, potentially new mechanisms of drug action. We show here that the presence of both an iodido ligand and a sigma-donor/pi-acceptor phenylazopyridine ligand confers remarkable inertness toward ligand substitution on the half-sandwich "piano-stool" ruthenium arene complexes [(eta(6)-arene)Ru(azpy...

متن کامل

Cruciaromaticity in organometallic compounds

A recent suggestion, that transition metal complexes of unsaturated ligands can be regarded as cruciconjugated, is explored by studies of various complexes of Fe(II), the aromaticity of the resulting i systems being analyzed in terms of PMO theory. This approach is also applied to porphyrin. The conclusions are supported by preliminary SCF and MNDO calculations.

متن کامل

Therapeutic Organometallic Compounds

Most drugs used today are purely organic compounds. Especially after the enormous success of the cisplatin (Fig 1) in tumor treatment, interest in metal complexes has grown (Allardyce & Dyson, 2006). Synthetic organometallic compounds are generally considered to be toxic or non-compatible with biological systems. Despite this perception, the medicinal properties of organometallic compounds, in ...

متن کامل

Activation Mechanisms for Organometallic Anticancer Complexes

Organometallic complexes offer potential for design as anticancer drugs. They can act as inert scaffolds and specifically inhibit enzymes such as kinases, or as pro-drugs which undergo activation by various mechanisms. The activation of metallocenes, arene, alkyl or aryl complexes by hydrolysis, and metalor ligandbased redox reactions is discussed.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Medicinal Chemistry

سال: 2011

ISSN: 0022-2623,1520-4804

DOI: 10.1021/jm100020w